By continuing to use the site you agree to our Privacy & Cookies policy

HPV vaccine indicated for treating anal cancers

The European Commission has approved the use of Gardasil – the quadrivalent human papillomavirus vaccine – for preventing anal precancerous lesions and anal cancers that are causally related to certain oncogenic HPV types in men and women.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units 
or

newsletterpromo